| Literature DB >> 33355852 |
Karen Andrea Weissmann1,2, Virginie Lafage3, Carlos Barrios Pitaque1, Renaud Lafage3, Carlos M Huaiquilaf4, Bryan Ang3, Ronald G Schulz2.
Abstract
STUDYEntities:
Keywords: Comorbidity; Complications; Perinatal; Scoliosis
Year: 2020 PMID: 33355852 PMCID: PMC8696062 DOI: 10.31616/asj.2020.0263
Source DB: PubMed Journal: Asian Spine J ISSN: 1976-1902
Articles that studied the correlation between known parameters and complications in neuromuscular scoliosis
| Variable | No. of studies | Reference | Our study |
|---|---|---|---|
| Demographics | |||
| Age >13 yr | 2 | [ | No, low Risser yes |
| Nonwhite race | 1 | [ | Not analyzed |
| Family income | 1 | [ | No, same results public/private hospital |
| Comorbidities | |||
| ≥1 known comorbidity | 2 | [ | Yes |
| Pulmonary comorbidity | 3 | [ | No |
| Known diagnosis: myelomeningocele or Duchenne | 4 | [ | Yes |
| Weight under 5% or over 95% | 2 | [ | No |
| Epilepsy | 1 | [ | No |
| Previous surgery | 1 | [ | No |
| Non-ambulatory | 4 | [ | Yes |
| Curves characteristics | |||
| Curve magnitude | 4 | [ | No |
| Curve rigidity | 1 | [ | No |
| Pelvic obliquity | 2 | [ | No |
| Surgery related | |||
| No. of levels instrumented | 1 | [ | Yes |
| One versus double staged surgery | 1 | [ | No |
| Type of instrumentation | 4 | [ | No |
| Osteotomies | 1 | [ | No |
| Surgical time | 2 | [ | Yes |
| Blood loss | 3 | [ | Yes |
| Inadequate reduction (LL or PO) | 1 | [ | Yes, for major complications |
LL, lumbar lordosis; PO, pelvic obliquity.
Primary diagnosis
| Diagnosis | No. of frequency |
|---|---|
| Neuropathics | |
| First motoneuron | |
| Cerebral palsy | 20 |
| Chiari type I | 4 |
| Siringomyelia | 3 |
| Intradural tumors | 2 |
| Spinocerebelar ataxia | 1 |
| Spinal cord trauma | 2 |
| Second motoneuron | |
| Charcot–Marie–Tooth | 1 |
| Spinal atrophie type II | 3 |
| Congenital hypothonia | 6 |
| Mixed | |
| Tetherd cord | 2 |
| Myelomeningocele | 8 |
| Myopathic | |
| Duchenne syndrome | 1 |
| Central core disease | 1 |
| Colagenopathies | |
| Marfan syndrome | 3 |
| Ehler–Danlos syndrome | 7 |
Complications
| Complication | Rate (%) |
|---|---|
| Superficial infection | 3.13 |
| Deep infection | 4.7 |
| Occipital pressure sore | 1.6 |
| Bilateral pneumonia | 4.7 |
| Minor pneumothorax/atelectasis | 4.7 |
| Varicella | 1.6 |
| Intraoperative screw pullout repositioned during same surgery | 1.6 |
| Unidentified fever for 2 days | 4.7 |
| Incidental durotomy | 3.13 |
| Hypovolemic shock | 4.7 |
| Tongue biting | 1.6 |
| Postoperative convulsions | 3.13 |
| Paraparesis (complete recovery 3 weeks) | 1.6 |
| Postoperative paralytic ileum | 1.6 |
| Late complications | |
| Proximal screw pullout due to proximal junctional kyphosis | 3.13 |
| Pedicle fracture due to traumatic accident | 1.6 |
| Nonunion | 3.13 |
Pre- and postoperative radiographic measurements
| Measurement | Preoperative | Postoperative | Correction | 2-yr FU | % Correction at 2-yr FU | ||
|---|---|---|---|---|---|---|---|
| Max Cobb (°) | 65.7± 25.5 | 30.6±22.2 | −33.9±14.2 | 0.000 | 33.9±23.6 | 3.2±8.3 | 0.026 |
| Bending (°) | 56.1±28.2 | - | 11.2±16.5 | 0.000 | - | - | - |
| Traction (°) | 50.91±25.9 | - | 18.9±12.7 | 0.000 | - | - | - |
| Pelvic obliquity (°) | 12.34±16.88 | 6.54±10.14 | −3.5±10.2 | 0.017 | 6.3±8.7 | 0.3±6.8 | 0.772 |
| Apical vertebral rotation (°) | 18.9±12.5 | 10.5±11.1 | −7.5±13.1 | 0.000 | 11.2±10.7 | 1.1±8.7 | 0.461 |
| Lordosis cervical (°) | 13.74±13.5 | 17.6±17.0 | 1.7±15.2 | 0.405 | 14.5±13.6 | −5.2±16.3 | 0.041 |
| Thoracic kyphosis (°) | 41.0±28.5 | 34.1±17.46 | 8.4±24.5 | 0.015 | 33.8±19.57 | 0.9±9.3 | 0.507 |
| Lordosis lumbar (°) | 54.6±19.85 | 51.89±15.2 | −3.9±15.28 | 0.066 | 49.1±16.1 | −2.4±12.1 | 0.190 |
| Sacral slope (°) | 35.6±11.13 | 35.0±10.67 | −2.1±6.7 | 0.836 | 34.0±8.1 | 0.5±6.1 | 0.821 |
| Pelvic incidence (°) | 46.1±21.56 | 48.9±16.0 | −2.9±6.5 | 0.495 | 47.3±14.8 | −1.0±6.2 | 0.533 |
| Pelvic tilt (°) | 13.2±11.62 | 13.87±10.3 | −0.6±6.9 | 0.760 | 14.0±11.6 | 0.3±7.0 | 0.750 |
| Sagittal vertical axis (mm) | 26.75±39.3 | 28.8±46.5 | 2.4±59.8 | 0.766 | 34.0±39.8 | 5.1±50.0 | 0.493 |
| T9SPI (°) | 11.5±11.0 | 8.3±8.8 | −2.9±12.2 | 0.085 | 9.1±7.5 | −0.5±8.5 | 0.702 |
| T1SPI (°) | 2.0±6.8 | 3.4±7.0 | 1.3±7.9 | 0.206 | 5.1±5.1 | 1.7±8.8 | 0.303 |
Values are presented as mean±standard deviation. Bold type is considered statistically significant.
FU, follow-up; SPI, spino-pelvic inclination.
Laboratory parameters pre- to postoperative
| Variable | Preoperative | Intraoperative | Postoperative | At discharge |
|---|---|---|---|---|
| Hematocrit (%) | 40.35±3.49 | 30.88±4.85 | 28.64±4.8 | 30.16±4.11 |
| Hemoglobin (g/dL) | 13.26±1.4 | 10.51±1.58 | 9.9±1.74 | 12.44±12.52 |
| Platelets (thousand/field) | 273.610±72.23 | - | - | - |
| Activated partial thromboplastin time (sec) | 30.39±3.57 | - | - | - |
| Prothrombin (%) | 84.33±26.95 | - | - | - |
| Glucose (mg/dL) | 87.61±8.35 | - | - | - |
| Blood urinary nitrogen (mg/dL) | 14.43±4.72 | - | - | - |
| Temperature (ºC) | 36.06±1.37 | - | 35.9±0.99 | - |
| Medial arterial pressure (mm Hg) | 110.31/63.34 | - | 102.61/57.07 | - |
| Heart rate (bpm) | 84.74±18.72 | - | - | - |
| Saturation O2 (%) | 98.26±1.48 | - | - | - |
| PH | - | 7.35±0.09 | - | - |
| PCO2 (mmH2O) | - | 41.67±7.9 | - | - |
| PO2 (mmH2O) | - | 9.63±66.70 | - | - |
| C-reactive protein day 1 (mg/L) | - | - | 9.0±7.5 | - |
| C-reactive protein day 3 (mg/L) | - | - | 115.65±88.96 | - |
| C-reactive protein day 7 (mg/L) | - | - | 81.90±54.21 | - |
Values are presented as mean±standard deviation or number.
PCO2, partial pressure of carbon dioxide; PO2, partial pressure of oxygen.
Bleeding
| Variable | Mean±standard deviation | Min–max |
|---|---|---|
| Intraoperative bleeding (mL) | 938.89±668.016 | 150–4,000 |
| Total drain debit (mL) | 405.36±387.47 | 0–1,875 |
| Total blood loss (mL) | 1,423.21±866.35 | 175–4,425 |
| Intraoperative transfusions | 1.09±0.937 | 0–1 |
| Postoperative transfusions | 0.43±0.47 | 0–3 |
Risk assessment for complications
| Variable | Category | With complication | No complication | |
|---|---|---|---|---|
| Demographic | Age (yr) | 14.86±2.44 | 15.44±4.36 | 0.498 |
| Sex (male:female) | 11:14 | 25:14 | 0.093 | |
| Preop weight (kg) | 45.06±14.88 | 45.93±16.90 | 0.840 | |
| Preop size (cm) | 148.8±15.4 | 146.7±19.14 | 0.730 | |
| Hospital (public/private) | 18/10 | 15/21 | 0.369 | |
| No. of comorbidities | 3.96±2.5 | 2.47±1.6 | 0.009 | |
| Previous surgeries (yes/no) | 19/9 | 21/15 | 0.302 | |
| Thelarche age (yr) | 9.75±2.5 | 10.57±1.13 | 0.464 | |
| Menarche age (yr) | 12.65±1.7 | 12.93±1.7 | 0.589 | |
| Preop brace (yes/no) | 12/16 | 9/27 | 0.107 | |
| Allergies (yes/no) | 8/20 | 10/26 | 0.320 | |
| Ambulatory status (yes/no) | 16/12 | 24/11 | 0.250 | |
| No. of seizures (/mo) | 0.5±1.2 | 0.28±0.9 | 0.390 | |
| No. of UTI (/yr) | 0.9±1.5 | 0.3±1.1 | 0.095 | |
| No. of LRTI (/yr) | 1.0±1.7 | 0.67±1.5 | 0.458 | |
| No. of patients (ASA I/II/III) | 4/17/7 | 12/18/6 | 0.207 | |
| Perinatal | Birth weight (kg) | 3.176±739 | 3194±596 | 0.914 |
| Birth size (cm) | 48.23±4.8 | 48.07±3.83 | 0.873 | |
| Delivery (wk) | 37.62±2.9 | 38.17±2.6 | 0.436 | |
| Pathological pregnancy (normal/pathological) | 6/31 | 6/20 | 0.273 | |
| Delivery (eutocic/c-section) | 16/9 | 18/17 | 0.609 | |
| Perintal pathology (no/yes) | 14/13 | 28/8 | 0.029 | |
| Laboratory | Preop glicemia (mg/dL) | 84.7±8.2 | 89.9±7.9 | 0.016 |
| Preop blood bitrogen (mg/dL) | 15.75±5.0 | 13.4±4.3 | 0.055 | |
| Hematocrit preop (%) | 40.4±4.2 | 40.3±4.2 | 0.973/0.908 | |
| Hemoglobin preop (g/dL) | 13.3±1.8 | 13.27±1.1 | - | |
| Surgical | Rod material (titanium/CrCo/both) | 19/7/2 | 16/19/1 | 0.074 |
| All screws/low density | 23/5 | 24/12 | 0.010 | |
| No. of instrumented levels | 13.93±2.9 | 12.31±3.3 | 0.044 | |
| LIV to pelvis (yes/no) | 8/28 | 11/17 | 0.458 | |
| Surgical technique (VCA/AD) | 13/15 | 21/15 | 0.244 | |
| Osteotomies Schawb (1–6) | 0/11/2/0/0/0 | 0/11/2/1/0/0 | 0.592 | |
| Simultaneous dethethering (yes/no) | 4/24 | 4/32 | 0.495 | |
| Surgical time (min) | 245.0±80.2 | 189.7±86.7 | 0.012 | |
| Bleeding (mL) | 1,112±865 | 800±418 | 0.065 | |
| Use of intravenous TXA (yes/no) | 17/19 | 18/10 | 0.134 | |
| Use of topical TXA (yes/no) | 29/7 | 24/4 | 0.296 | |
| No. of transfusions–red blood cells | 3±2.0 | 1.75±1.2 | 0.123 | |
| No. of transfusions–platelet | 2.88±2.9 | 3.7±3.1 | 0.700 | |
| Hematocrit (%) | 27.6±5.7 | 29.5±3.9 | 0.170 | |
| Hemoglobine (g/dL) | 9.5±2.0 | 10.23±1.4 | 0.092 | |
| pH | 7.3 | 7.3 | 0.578 | |
| PO2 (mmH2O) | 111.9 | 86.5 | 0.298 | |
| pCO2 (mmH2O) | 40.7 | 42.7 | 0.465 | |
| Drain (superficial) | 17 | 11 | 0.021 | |
| Drain (deep) | 10 | 18 | 0.003 | |
| Intensive care unit | 4.65 | 2.29 | 0.178 | |
| Intensive treatment unit | 3.16 | 1.26 | 0.108 | |
| Medical-surgical unit | 6.77 | 3.55 | 0.094 | |
| Mechanical ventilation (yes/no) | 7/18 | 7/26 | 0.578 |
Values are presented as mean±standard deviation or number, unless otherwise stated. Bold type is considered statistically significant.
Preop, preoperative; Postop, postoperative; UTI, urinary tract infections; LRTI, lower respiratory tract infections; ASA, American Society of Anesthesiologists; LIV, lower instrumented vertebra; VCA, vertebral coplanar alignement; AD, apical derotation; TXA, tranexamic acid; PCO2, partial pressure of carbon dioxide; PO2, partial pressure of oxygen.
Radiological parameters and their complication risk
| Variable | Preoperative | Postoperative | ||||
|---|---|---|---|---|---|---|
|
|
| |||||
| With complications | Without complications | With complications | Without complications | |||
| Risser (0–V) | 3/5/1/1/8/10 | 3/2/6/3/11/11 | 0.362 | - | - | - |
|
| ||||||
| Curve magnitude (°) | 69.7±27.7 | 62.3±23.3 | 0.271 | 34.8±22.6 | 26.9±21.7 | 0.186 |
|
| ||||||
| Apical vertebral rotation (°) | 19.7±14.3 | 18.2±10.8 | 0.668 | 12.3±12.4 | 9.1±10.0 | 0.301 |
|
| ||||||
| Pelvic obliquity (°) | 7.27±8.4 | 16.8±21.0 | 0.050 | 8.4±12.5 | 5.1±8.0 | 0.220 |
|
| ||||||
| Cervical lordosis (°) | 13.2±11.9 | 14.2±14.9 | 0.782 | 16.6±16.6 | 18.4±17.4 | 0.683 |
|
| ||||||
| Thoracic kyphosis (°) | 40.9±31.8 | 41.2±25.7 | 0.976 | 28.9±15.2 | 38.2±18.1 | 0.035 |
|
| ||||||
| Lumbar lordosis (°) | 53.4±22.8 | 55.7±17.0 | 0.670 | 49.4±14.2 | 53.8±15.8 | 0.267 |
|
| ||||||
| Sacral slope (°) | 37.4±11.0 | 34.1±11.2 | 0.265 | 36.1±11.8 | 34.2±9.8 | 0.491 |
|
| ||||||
| Pelvic incidence (°) | 49.9±20.4 | 43.16±22.3 | 0.230 | 45.9±14.5 | 48.4±15.1 | 0.815 |
|
| ||||||
| Pelvic tilt (°) | 16.04±11.8 | 10.9±11.2 | 0.085 | 13.6±13.4 | 14.3±10.4 | 0.565 |
|
| ||||||
| Sagittal vertical axis (mm) | 28.1±29.9 | 25.5±46.7 | 0.812 | 43.6±32.2 | 26.3±44.2 | 0.364 |
|
| ||||||
| T9 spino-pelvic inclination (°) | 10.4±11.6 | 12.4±10.6 | 0.505 | 10.4±6.8 | 8.2±8.0 | 0.043 |
|
| ||||||
| T1 spino-pelvic inclination (°) | 0.9±7.3 | 3.0±6.5 | 0.265 | 5.3±5.8 | 4.9±4.5 | 0.091 |
Values are presented as number or mean±standard deviation, unless otherwise stated. Bold type is considered statistically significant.